“Managed virological reaction after treatment with daclatasvir/pegylated interferon and ribavirin as a component of a clinical trial in a cirrhotic human immunodeficiency infection ”, AJAHR, vol. 3, no. 1, pp. 23–25, Apr. 2015, Accessed: Oct. 28, 2026. [Online]. Available: https://kevinpage.org/index.php/AJAHR/article/view/700